These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 4050707)
1. Pharmacokinetics and pharmacodynamics of milrinone in chronic congestive heart failure. Benotti JR; Lesko LJ; McCue JE; Alpert JS Am J Cardiol; 1985 Oct; 56(10):685-9. PubMed ID: 4050707 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study. Anderson JL; Baim DS; Fein SA; Goldstein RA; LeJemtel TH; Likoff MJ J Am Coll Cardiol; 1987 Apr; 9(4):711-22. PubMed ID: 3549837 [TBL] [Abstract][Full Text] [Related]
3. Preload-dependent hemodynamic effects of milrinone in moderate heart failure. Remme WJ; van Hoogenhuyze DC; Kruijssen HA; Pieper PG; Bruggeling WA Cardiology; 1992; 80(2):132-42. PubMed ID: 1611632 [TBL] [Abstract][Full Text] [Related]
4. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside. Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022 [TBL] [Abstract][Full Text] [Related]
5. Short-term intravenous milrinone for severe congestive heart failure: the good, bad, and not so good. Varriale P; Ramaprasad S Pharmacotherapy; 1997; 17(2):371-4. PubMed ID: 9085331 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure. Baim DS; McDowell AV; Cherniles J; Monrad ES; Parker JA; Edelson J; Braunwald E; Grossman W N Engl J Med; 1983 Sep; 309(13):748-56. PubMed ID: 6888453 [TBL] [Abstract][Full Text] [Related]
7. Identification of the direct vasodilator effect of milrinone with an isolated limb preparation in patients with chronic congestive heart failure. Cody RJ; Müller FB; Kubo SH; Rutman H; Leonard D Circulation; 1986 Jan; 73(1):124-9. PubMed ID: 3940663 [TBL] [Abstract][Full Text] [Related]
8. Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation. Simonton CA; Chatterjee K; Cody RJ; Kubo SH; Leonard D; Daly P; Rutman H J Am Coll Cardiol; 1985 Aug; 6(2):453-9. PubMed ID: 4019930 [TBL] [Abstract][Full Text] [Related]
9. Assessment of long-term therapy with milrinone and the effects of milrinone withdrawal. Monrad ES; Baim DS; Smith HS; Lanoue AS; Silverman KJ; Gervino EV; Grossman W Circulation; 1986 Mar; 73(3 Pt 2):III205-12. PubMed ID: 3510776 [TBL] [Abstract][Full Text] [Related]
10. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness. Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774 [TBL] [Abstract][Full Text] [Related]
11. Effect of a single oral dose of milrinone on left ventricular diastolic performance in the failing human heart. Piscione F; Jaski BE; Wenting GJ; Serruys PW J Am Coll Cardiol; 1987 Dec; 10(6):1294-302. PubMed ID: 3680800 [TBL] [Abstract][Full Text] [Related]
12. Hemodynamic and clinical benefits with intravenous milrinone in severe chronic heart failure: results of a multicenter study in the United States. Anderson JL Am Heart J; 1991 Jun; 121(6 Pt 2):1956-64. PubMed ID: 2035427 [TBL] [Abstract][Full Text] [Related]
13. Correlation of the hemodynamic and pharmacokinetic profile of intravenous milrinone in the anesthetized dog. Alousi AA; Iwan T; Edelson J; Biddlecome C Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):59-66. PubMed ID: 6721624 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shock. Lindsay CA; Barton P; Lawless S; Kitchen L; Zorka A; Garcia J; Kouatli A; Giroir B J Pediatr; 1998 Feb; 132(2):329-34. PubMed ID: 9506650 [TBL] [Abstract][Full Text] [Related]
16. Acute dose range study of milrinone in congestive heart failure. Kubo SH; Cody RJ; Chatterjee K; Simonton C; Rutman H; Leonard D Am J Cardiol; 1985 Mar; 55(6):726-30. PubMed ID: 3976517 [TBL] [Abstract][Full Text] [Related]
17. Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique. Ludmer PL; Wright RF; Arnold JM; Ganz P; Braunwald E; Colucci WS Circulation; 1986 Jan; 73(1):130-7. PubMed ID: 3940664 [TBL] [Abstract][Full Text] [Related]
19. Intravenous milrinone following cardiac surgery: I. Effects of bolus infusion followed by variable dose maintenance infusion. The European Milrinone Multicentre Trial Group. Feneck RO J Cardiothorac Vasc Anesth; 1992 Oct; 6(5):554-62. PubMed ID: 1421066 [TBL] [Abstract][Full Text] [Related]
20. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension. Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]